Literature DB >> 24510902

Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia.

Yuhong Shi1, Joyce Hogue, Darshana Dixit, James Koh, John A Olson.   

Abstract

Parathyroid adenomas (PAs) causing primary hyperparathyroidism (PHPT) are histologically heterogeneous yet have been historically viewed as largely monotypic entities arising from clonal expansion of a single transformed progenitor. Using flow cytometric analysis of resected adenomatous parathyroid glands, we have isolated and characterized chief cells, oxyphil cells, and tumor-infiltrating lymphocytes. The parathyroid chief and oxyphil cells produce parathyroid hormone (PTH), express the calcium-sensing receptor (CASR), and mobilize intracellular calcium in response to CASR activation. Parathyroid tumor infiltrating lymphocytes are T cells by immunophenotyping. Under normocalcemic conditions, oxyphil cells produce ∼50% more PTH than do chief cells, yet display significantly greater PTH suppression and calcium flux response to elevated calcium. In contrast, CASR expression and localization are equivalent in the respective parathyroid cell populations. Analysis of tumor clonality using X-linked inactivation assays in a patient-matched series of intact tumors, preparatively isolated oxyphil and chief cells, and laser-captured microdissected PA specimens demonstrate polyclonality in 5 of 14 cases. These data demonstrate the presence of functionally distinct oxyphil and chief cells within parathyroid primary adenomas and provide evidence that primary PA can arise by both clonal and polyclonal mechanisms. The clonal differences, biochemical activity, and relative abundance of these parathyroid adenoma subpopulations likely reflect distinct mechanisms of disease in PHPT.

Entities:  

Keywords:  endocrine neoplasia; tumor heterogeneity

Mesh:

Substances:

Year:  2014        PMID: 24510902      PMCID: PMC3939880          DOI: 10.1073/pnas.1319742111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

Authors:  D G Gilliland; K L Blanchard; J Levy; S Perrin; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

2.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

3.  Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.

Authors:  M Kyle Cromer; Lee F Starker; Murim Choi; Robert Udelsman; Carol Nelson-Williams; Richard P Lifton; Tobias Carling
Journal:  J Clin Endocrinol Metab       Date:  2012-06-27       Impact factor: 5.958

4.  Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.

Authors:  James Koh; Moahad Dar; Brian R Untch; Darshana Dixit; Yuhong Shi; Zhao Yang; Mohamed Abdelgadir Adam; Holly Dressman; Xiaojuan Wang; Diane Gesty-Palmer; Jeffrey R Marks; Robert Spurney; Kirk M Druey; John A Olson
Journal:  Mol Endocrinol       Date:  2011-03-10

5.  Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor.

Authors:  Min Pi; Robert F Spurney; Qisheng Tu; Todd Hinson; L Darryl Quarles
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

6.  Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves.

Authors:  G P Mayer; J G Hurst
Journal:  Endocrinology       Date:  1978-04       Impact factor: 4.736

Review 7.  Primary hyperparathyroidism: a current perspective.

Authors:  Ronald A DeLellis; Peter Mazzaglia; Shamlal Mangray
Journal:  Arch Pathol Lab Med       Date:  2008-08       Impact factor: 5.534

8.  Ultrastructure of human parathyroid cells in health and disease.

Authors:  S Cinti; A Sbarbati
Journal:  Microsc Res Tech       Date:  1995-10-01       Impact factor: 2.769

9.  Parathyroid adenomas with pronounced lymphocytic infiltration: no evidence of autoimmune pathogenesis.

Authors:  K Y Lam; A C Chan; C Y Lo
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

10.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

View more
  18 in total

1.  MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.

Authors:  Andrew Arnold
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

2.  Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors.

Authors:  A K Arya; P Singh; U N Saikia; N Sachdeva; D Dahiya; A Behera; S D Rao; S K Bhadada
Journal:  J Endocrinol Invest       Date:  2019-09-18       Impact factor: 4.256

3.  Polyclonal origin of parathyroid tumors is common and is associated with multiple gland disease in primary hyperparathyroidism.

Authors:  Yuhong Shi; Pedram Azimzadeh; Sarada Jamingal; Shannon Wentworth; Janice Ferlitch; James Koh; Nariman Balenga; John A Olson
Journal:  Surgery       Date:  2018-01       Impact factor: 3.982

4.  Parathyroid-Targeted Overexpression of Regulator of G-Protein Signaling 5 (RGS5) Causes Hyperparathyroidism in Transgenic Mice.

Authors:  Nariman Balenga; James Koh; Pedram Azimzadeh; Joyce Hogue; Mostafa Gabr; Joseph P Stains; John A Olson
Journal:  J Bone Miner Res       Date:  2019-02-28       Impact factor: 6.741

5.  Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.

Authors:  Yue Ding; Qiang Zou; Yiting Jin; Jian Zhou; Hongying Wang
Journal:  Int Urol Nephrol       Date:  2019-11-04       Impact factor: 2.370

Review 6.  Intratumor heterogeneity in human parathyroid tumors.

Authors:  C Verdelli; G S Tavanti; S Corbetta
Journal:  Histol Histopathol       Date:  2020-05-29       Impact factor: 2.303

7.  Molecular pathways associated with transcriptional alterations in hyperparathyroidism.

Authors:  Fang Lee; Jie-Jen Lee; Woan-Ching Jan; Chih-Jen Wu; Han-Hsiang Chen; Shih-Ping Cheng
Journal:  Oncol Lett       Date:  2016-05-25       Impact factor: 2.967

8.  Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells.

Authors:  J Zuo; C Zhang; C Ren; D Pang; Y Li; X Xie; Z Tang; X Jiang
Journal:  Clin Transl Oncol       Date:  2014-10-16       Impact factor: 3.405

Review 9.  Uncoupling of secretion from growth in some hormone secretory tissues.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2014-07-08       Impact factor: 5.958

Review 10.  Single-cell approaches for molecular classification of endocrine tumors.

Authors:  James Koh; Nancy L Allbritton; Julie A Sosa
Journal:  Curr Opin Oncol       Date:  2016-01       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.